Current Perspectives on Emerging CAR-Treg Cell Therapy: Based on Treg Cell Therapy in Clinical Trials and the Recent Approval of CAR-T Cell Therapy

The Journal of The Korean Society for Transplantation Pub Date : 2017-12-01 DOI:10.4285/JKSTN.2017.31.4.157

K. Kang, Junho Chung, Jaeseok Yang, H. Kim

引用次数: 0

Abstract

Current Perspectives on Emerging CAR-Treg Cell Therapy: Based on Treg Cell Therapy in Clinical Trials and the Recent Approval of CAR-T Cell Therapy Koeun Kang, Junho Chung, M.D., Jaeseok Yang, M.D. and Hyori Kim, Ph.D. Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Transplantation Center, Department of Surgery, Seoul National University Hospital, Biomedical Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea

查看原文本刊更多论文

新兴CAR-Treg细胞疗法的当前观点:基于临床试验中的Treg细胞疗法和最近批准的CAR-T细胞疗法

新兴CAR-Treg细胞疗法的当前观点:基于临床试验中的Treg细胞疗法和最近批准的CAR-T细胞疗法Koeun Kang, Junho Chung, M.D.， Jaeseok Yang, M.D.和Hyori Kim，博士，首尔国立大学医学院生物化学和分子生物学学系，移植中心，外科，首尔国立大学医院，生物医学研究中心，峨山生命科学研究所，峨山医学中心，首尔，韩国

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

The Journal of The Korean Society for Transplantation

自引率

0.00%

发文量